Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quest L-Arginine 500mg capsules
091101000BBJVCS
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Quest L-Glutamine 500mg capsules
091101000BBPXFF
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Quest L-Lysine High Potency 1000mg tablets
091101000BBUQFD
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Sanatogen High Protein powder
091101000BBQCA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Serine powder
091101000AAGBGB
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar DLPA 500mg capsules
091101000BBLWA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar L-Arginine 500mg capsules
091101000BBVCCS
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar L-Glutathione 50mg capsules
091101000BBMNA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar L-Lysine 1000mg tablets
091101000BBNAFD
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar L-Lysine 500mg capsules
091101000BBRWA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar L-Tyrosine 500mg capsules
091101000BBIFFE
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Solgar Soya Lecithin 95 granules
091101000BBILA0
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Sorbitol 70% solution non-crystallising
091101000AABTBT
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
SynBio L-Arginine 500mg capsules
091101000BBUUCS
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Syrup
091101000AABQBQ
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Syrup unpreserved
091101000AACDCD
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Tyrosine 500mg capsules
091101000AAFEFE
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Valine 50mg/5ml oral solution
091101000AADZDZ
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Valine powder
091101000AAGAGA
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.